Collegium Pharmaceutical Inc. (COLL) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 TECHNOLOGY CENTER DRIVE
STOUGHTON, MA 02072
State of Incorp. VA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments310,548173,688186,426174,116170,019146,633
Cash and cash equivalents238,947173,688186,426174,116170,019146,633
Short-term investments71,601     
Receivables179,525183,119105,84483,32072,95377,946
Inventory, net of allowances, customer advances and progress billings32,33246,50117,39415,6149,6437,817
Inventory32,33246,50117,39415,6149,6437,817
Prepaid expense 5,9385,6143,6023,2801,2223,035
Other current assets 935727601411,008
Other undisclosed current assets9,16411,0102,2501,4981,7421,073
Total current assets:537,600419,989315,543277,888255,720237,512
Noncurrent Assets
Operating lease, right-of-use asset6,0296,8617,6448,3919,047
Property, plant and equipment15,98319,52119,49118,98811,8549,274
Intangible assets, net (including goodwill), including:555,565701,163268,723335,90429,50344,255
Goodwill133,857133,695    
Intangible assets, net (excluding goodwill)421,708567,468268,723335,904  
Other undisclosed intangible assets, net (including goodwill)     29,50344,255
Restricted cash and investments1,0472,5472,5472,547  
Deferred income tax assets26,25923,95078,042  
Other noncurrent assets82510087123178204
Total noncurrent assets:605,708754,142376,534365,95350,58253,733
TOTAL ASSETS:1,143,3081,174,131692,077643,841306,302291,245
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46,26339,62333,40334,67239,72742,701
Accounts payable8,6923,4944,18910,0166,24712,150
Accrued liabilities37,57136,12929,21424,65633,48030,551
Debt183,333162,50048,35347,4954,4891,642
Estimated litigation liability   2,750   
Other undisclosed current liabilities228,319231,603195,060157,284157,549144,783
Total current liabilities:457,915433,726279,566239,451201,765189,126
Noncurrent Liabilities
Long-term debt and lease obligation483,838538,451209,583218,35917,1059,858
Long-term debt, excluding current maturities483,838538,451201,632209,5947,6679,858
Liabilities, other than long-term debt6,1247,112   676
Other liabilities      676
Operating lease, liability6,1247,1127,9518,7659,438
Other undisclosed noncurrent liabilities   (7,951)(8,765)  
Total noncurrent liabilities:489,962545,563209,583218,35917,10510,534
Total liabilities:947,877979,289489,149457,810218,870199,660
Equity
Equity, attributable to parent195,431194,842202,928186,03187,43291,585
Common stock383736353433
Treasury stock, value(137,381)(61,924)(42,861)   
Additional paid in capital565,949538,073502,095519,143447,297428,729
Accumulated other comprehensive income (loss)14     
Accumulated deficit(233,189)(281,344)(256,342)(333,147)(359,899)(337,177)
Total equity:195,431194,842202,928186,03187,43291,585
TOTAL LIABILITIES AND EQUITY:1,143,3081,174,131692,077643,841306,302291,245

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues566,767463,933276,868310,016296,701280,413
Cost of revenue
(Cost of Goods and Services Sold)
(240,598)(254,445)(126,251)(130,180)(193,660)(165,677)
Gross profit:326,169209,488150,617179,836103,041114,736
Operating expenses(159,208)(176,169)(132,989)(123,604)(126,789)(135,421)
Operating income (loss):166,96133,31917,62856,232(23,748)(20,685)
Nonoperating income
(Investment Income, Nonoperating)
15,6151,047122321,9351,687
Interest and debt expense(106,843)(63,213)(21,014)(28,882)(909)(20,130)
Income (loss) from continuing operations before income taxes:75,733(28,847)(3,374)27,582(22,722)(39,128)
Income tax expense (benefit)(27,578)3,84574,891(830)  
Income (loss) from continuing operations:48,155(25,002)71,51726,752(22,722)(39,128)
Income (loss) before gain (loss) on sale of properties:71,51726,752(22,722)(39,128)
Net income (loss) available to common stockholders, basic:48,155(25,002)71,51726,752(22,722)(39,128)
Interest on convertible debt5,889 4,675   
Other undisclosed net income available to common stockholders, diluted      
Net income (loss) available to common stockholders, diluted:54,044(25,002)76,19226,752(22,722)(39,128)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):48,155(25,002)71,51726,752(22,722)(39,128)
Other comprehensive loss      
Comprehensive income (loss):48,155(25,002)71,51726,752(22,722)(39,128)
Other undisclosed comprehensive income, net of tax, attributable to parent14     
Comprehensive income (loss), net of tax, attributable to parent:48,169(25,002)71,51726,752(22,722)(39,128)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: